P

Inventor

LIANG WEI-CHING

US51 patents
⚠️ This page may combine multiple inventors who share the name “LIANG WEI-CHING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENENTECH INC

34 patents
US7691977B2Apr 6, 2010

Anti-VEGF antibodies

GENENTECH INC83 citations98
US8968741B2Mar 3, 2015

Anti-CD22 antibodies and immunoconjugates and methods of use

GENENTECH INC34 citations97
US7758859B2Jul 20, 2010

Anti-VEGF antibodies

GENENTECH INC76 citations97
US7811785B2Oct 12, 2010

Anti-VEGF antibodies

GENENTECH INC32 citations96
US10017572B2Jul 10, 2018

Anti-tigit antibodies and methods of use

GENENTECH INC19 citations93
US7973138B2Jul 5, 2011

Antibodies

GENENTECH INC16 citations92
US10150813B2Dec 11, 2018

Anti-B7-H4 antibodies and immunoconjugates

GENENTECH INC12 citations84
US10059768B2Aug 28, 2018

Anti-B7-H4 antibodies and immunoconjugates

GENENTECH INC9 citations84
US9951133B2Apr 24, 2018

Anti-CD33 antibodies and immunoconjugates

GENENTECH INC12 citations84
US9562099B2Feb 7, 2017

Anti-B7-H4 antibodies and immunoconjugates

GENENTECH INC16 citations84
US9353177B2May 31, 2016

Anti-VEGF antibodies

GENENTECH INC8 citations83
US9018357B2Apr 28, 2015

Anti-VEGF antibodies

GENENTECH INC4 citations83
US8975381B2Mar 10, 2015

Anti-VEGF antibodies

GENENTECH INC5 citations83
US10501545B2Dec 10, 2019

Anti-CLL-1 antibodies and methods of use

GENENTECH INC6 citations82
US10047158B2Aug 14, 2018

Anti-TIGIT antibodies and methods of use

GENENTECH INC13 citations82
US8920805B2Dec 30, 2014

Inhibition of tumor metastasis by anti-neuropilin 2 antibodies

GENENTECH INC7 citations79
US11286302B2Mar 29, 2022

Anti-B7-H4 antibodies and immunoconjugates

GENENTECH INC4 citations73
US11230600B2Jan 25, 2022

Anti-B7-H4 antibodies and immunoconjugates

GENENTECH INC3 citations73
US10266597B2Apr 23, 2019

Anti-CLL-1 antibodies and immunoconjugates

GENENTECH INC3 citations72
US10239947B2Mar 26, 2019

Anti-CLL-1 antibodies and immunoconjugates

GENENTECH INC1 citations72
US10227412B2Mar 12, 2019

Anti-CLL-1 antibodies and immunoconjugates

GENENTECH INC1 citations72
US9175089B2Nov 3, 2015

Anti-LGR5 antibodies and immunoconjugates

GENENTECH INC5 citations72
US11512143B2Nov 29, 2022

Anti-HtrA1 antibodies and methods of use thereof

GENENTECH INC1 citations71
US10421821B2Sep 24, 2019

Anti-HtrA1 antibodies and methods of use thereof

GENENTECH INC2 citations71
US10421822B2Sep 24, 2019

Anti-HtrA1 antibodies and methods of use thereof

GENENTECH INC4 citations71
US9738727B2Aug 22, 2017

Anti-HtrA1 antibodies and methods of use

GENENTECH INC6 citations68
US12281165B2Apr 22, 2025

Anti-B7-H4 antibodies and immunoconjugates

GENENTECH INC0 citations62
US12134649B2Nov 5, 2024

Anti-B7-H4 antibodies and immunoconjugates

GENENTECH INC0 citations62
US11084877B2Aug 10, 2021

Anti-CLL-1 antibodies and immunoconjugates

GENENTECH INC0 citations62
US10556951B2Feb 11, 2020

Anti-CD33 antibodies and immunoconjugates

GENENTECH INC1 citations62
US9751946B2Sep 5, 2017

Anti-CLL-1 antibodies and immunoconjugates

GENENTECH INC1 citations62
US11466087B2Oct 11, 2022

Anti-CLL-1 antibodies and methods of use

GENENTECH INC0 citations61
US11919948B2Mar 5, 2024

Isoform-selective anti-TGFβ antibodies and methods of use

GENENTECH INC0 citations51
US9675707B2Jun 13, 2017

Anti-TAT226 antibodies and immunoconjugates

GENENTECH INC0 citations51

LIANG WEI-CHING

6 patents

FUH GERMAINE

4 patents

EBENS JR ALLEN J

3 patents

DENNIS MARK S

1 patent

WU YAN

1 patent

WU XIUMIN

1 patent

Showing the top 50 of 51 patents by PatentIndex Score.